Garland S, Park S N, Ngan H Y S, Frazer I, Tay E H, Chen C J, Bhatla N, Pitts M, Shin H R, Konno R, Smith J, Pagliusi S, Park J S
Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, 132 Grattan Street, Carlton, Victoria 3053, Australia.
Vaccine. 2008 Oct 9;26(43):5435-40. doi: 10.1016/j.vaccine.2008.07.077. Epub 2008 Aug 14.
Asia accounts for more than half of all cases of cervical cancer registered globally and improving prevention is urgently needed. A range of tools and strategies is now available to effectively prevent this disease, including two new prophylactic HPV vaccines approved and recommended for adolescents and young women. However, without communication these tools may have little impact on disease burden. The conferences of the Asia Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN) bring together clinicians and scientists whose work is related to genital infections, particularly HPV, cervical dysplasia and neoplasia, as well as other anogenital cancers, with the aim of improving communication on prevention through human papillomavirus (HPV) vaccination and screening in Asian countries. The scope of this year's AOGIN conference was to extend education to include health workers, family doctors, paediatricians, governmental health agencies, and the general public through patients' testimonials that can reach out to women raising awareness of this silent disease. Community based initiatives and awareness campaigns were also reported, and can empower the people to engage in a dialog with local governments towards prioritization of cancer prevention programs, achieving more for the public than isolated actions. Parents and teachers are encouraged to communicate about these issues within families and schools. Evidence was discussed that males can participate in cervical cancer control as well, and prevention programs involving men should not be neglected as they may reduce genital disease burden in women. Opinion leaders proposed prevention measures to be considered for governmental decisions. While each country develops a locally appropriate policy for cervical cancer control there is a need to revise these programs regularly, as knowledge increases in response to public need, as well as to gather evidence about disease burden and the effectiveness of education and interventions. In conclusion, AOGIN is committed to improve communication with patients, health authorities, professional organizations and opinion leaders towards strengthening cervical cancer prevention in Asia, to achieve a timely steep reduction in this cancer.
亚洲的宫颈癌病例占全球登记病例的一半以上,因此迫切需要改进预防措施。现在有一系列工具和策略可有效预防这种疾病,包括两种新的预防性人乳头瘤病毒(HPV)疫苗,已获批准并推荐给青少年和年轻女性。然而,如果缺乏沟通,这些工具对疾病负担的影响可能微乎其微。亚洲大洋洲生殖器感染和肿瘤研究组织(AOGIN)会议汇聚了临床医生和科学家,他们的工作涉及生殖器感染,特别是HPV、宫颈发育异常和肿瘤,以及其他肛门生殖器癌症领域,目的是通过在亚洲国家开展人乳头瘤病毒(HPV)疫苗接种和筛查来加强预防方面的沟通。今年AOGIN会议的范围是通过患者证言将教育扩展到卫生工作者、家庭医生、儿科医生、政府卫生机构和公众,从而提高女性对这种隐匿性疾病的认识。会议还报告了基于社区的倡议和提高认识运动,这些活动可促使民众与地方政府进行对话,以便优先开展癌症预防项目,比孤立行动能为公众带来更多益处。鼓励家长和教师在家庭和学校内就这些问题进行沟通。会上讨论了男性也可参与宫颈癌防治的证据,涉及男性的预防项目不应被忽视,因为这可能减轻女性的生殖器疾病负担。意见领袖提出了供政府决策时考虑的预防措施。虽然每个国家都制定了适合本国国情的宫颈癌控制政策,但随着公众需求增加知识不断更新,以及收集有关疾病负担和教育及干预措施有效性的证据,有必要定期修订这些项目。总之,AOGIN致力于加强与患者、卫生当局、专业组织和意见领袖的沟通,以强化亚洲的宫颈癌预防工作,及时大幅降低这种癌症的发病率。